Email LinkedIn Twitter

Metric-Based Presentations

These online survey-based studies are ideal for learning what other companies are doing, how they measure what they do, what resources they devote to activities, what they find effective, and other insights. These are useful for doing a gap analysis.

Show details for Brand Management and Product LeadershipBrand Management and Product Leadership
Show details for Business CommunicationsBusiness Communications
Show details for Business OperationsBusiness Operations
Show details for Clinical OperationsClinical Operations
Show details for Competitive and Business IntelligenceCompetitive and Business Intelligence
Show details for Customer ServiceCustomer Service
Show details for GBC ConferencesGBC Conferences
Show details for Human ResourcesHuman Resources
Show details for IndustryIndustry
Show details for InternetInternet
Show details for Knowledge ManagementKnowledge Management
Show details for Managed CareManaged Care
Show details for Market Research, Analytics and ForecastingMarket Research, Analytics and Forecasting
Show details for Marketing ManagementMarketing Management
Show details for Medical AffairsMedical Affairs
Show details for MembershipsMemberships
Show details for New Product DevelopmentNew Product Development
Show details for Patient Focused ServicesPatient Focused Services
Hide details for Product LaunchProduct Launch
Case Studies in Successful Re-Launch: Zithromax and Wellbutrin This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to sign-up for a complimentary tour of "Case Studies in Successful Re-Launch: Zithromax and Wellbutrin" Study Overview Successfully re-launching a pharmaceutical product is a difficult feat... (ID 4776)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1365.61


Product Relaunch: Setting Strategy for Success This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to sign-up for a complimentary tour of "Product Relaunch: Setting Strategy for Success" Study Overview The need to re-launch a pharmaceutical product can happen for many reasons... (ID 4775)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1126.00


Sales Force Enthusiasm: Garnering Support for Product Re-Launch This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to sign-up for a complimentary tour of "Sales Force Enthusiasm: Garnering Support for Product Re-Launch" Study Overview Garnering sales force support for a re-launched pharmaceutical product can be a Sisyphean effort... (ID 4774)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1382.00


Product Re-Launch: Determining the Ideal Marketing Investment This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to sign-up for a complimentary tour of "Product Re-Launch: Determining the Ideal Marketing Investment" Study Overview When product managers endeavor to re-launch a pharmaceutical product, they face numerous obstacles in securing funding for a re-launch and in determining the ideal mix of activities... (ID 4773)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1132.00


Product Re-Launch Success: Key Findings 
Non-members: Click here to sign-up for a complimentary tour of "Product Re-Launch Success: Key Findings" Study Overview Re-launching a pharmaceutical product is a marketing challenge that no brand executive wants to face, but many often do... (ID 4772)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $284.00


Product Character & Position: Choosing Changes for New Growth This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Non-members: Click here to sign-up for a complimentary tour of "Product Character & Position: Choosing Changes for New Growth" Study Overview Most companies eventually must face the daunting task of re-launching a pharmaceutical product... (ID 4771)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1124.00


Report Summary -- Product Re-Launch Excellence: Transforming Lackluster Pharmaceutical Products Into Market Success Stories 
Re-launching a pharmaceutical product is a marketing challenge that no brand executive wants to face, but many often do... (ID SM-170A)
Companies Profiled: Bayer Healthcare, Sanofi-aventis, UCB Pharma, Schering-Plough, more ...
Price: $0.00


Best Practices in Global Pharmaceutical Launches 
Discover how the world's leading pharmaceutical companies develop global launch strategies, manage launch teams, cultivate thought leader support, integrate marketing activities, and conduct a host of other critical launch activities... (ID SM-120)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline, more ...
Price: $7000.00


Product Re-Launch Excellence: Transforming Lackluster Pharmaceutical Products Into Market Success Stories 
Product re-launch is the hobgoblin of the pharmaceutical and biotech sector... (ID SM-170)
Companies Profiled: Bayer Healthcare, Sanofi-aventis, UCB Pharma, Schering-Plough, more ...
Price: $4651.00


Pharma Thought Leadership: Be a Thought Leader, Manage Influential Organizations, Launch a Winner 
Best Practices’ Pharma Thought Leadership series examines thought leadership in the context of patient advocacy while creating effective relationships and global product launches... (ID SMS-156)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, AstraZeneca, Bristol-Myers Squibb, more ...
Price: $18400.00


Aligning Field-Based Medical Programs with Overall Objectives This document contains Graphics and a detailed Process Map.This document contains Graphics and a detailed Process Map.
Study Overview Field-based medical programs must align in all elements with the overall strategy and objectives of a company... (ID 4643)
Companies Profiled: AstraZeneca, Sanofi-aventis, Merck, Schering-Plough, more ...
Price: $2128.95


Key Factors in Building Pharmaceutical Business Through Thought Leader Relationships This document contains Graphics, a detailed Process Map and a practice summary Matrix.This document contains Graphics, a detailed Process Map and a practice summary Matrix.This document contains Graphics, a detailed Process Map and a practice summary Matrix.
Study Overview Primary medical thought leader relationships are the keystone to every successful new product launch... (ID 4642)
Companies Profiled: AstraZeneca, Sanofi-aventis, Merck, Schering-Plough, more ...
Price: $945.00


Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters 
The findings in this Best Practices Benchmarking® Report will enable pharmaceutical executives to understand the winning strategies, practices, team structures and investment patterns that distinguish successful new product development and marketing planning... (ID SM-124)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Bristol-Myers Squibb, Amgen, more ...
Price: $7962.00


Lifecycle Management for Pharmaceutical Launches This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Life cycle management (LCM) ultimately drives the long-term success of any pharmaceutical product... (ID 4573)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline, more ...
Price: $1424.95


Thought Leader Development for Global Pharmaceutical Launches This document contains Metrics.
A pharmaceutical company’s relationship with key thought leaders is vital to the success of a new product because thought leaders communicate opinions and recommendations that are often the deciding factor in influencing a physician to prescribe a new drug... (ID 4569)
Companies Profiled: Sanofi-aventis, Merck, Eli Lilly, GlaxoSmithKline, more ...
Price: $768.95


Managing Cross-Functional Pharmaceutical Launch Teams This document contains Metrics, Graphics, a detailed Process Map and a practice summary Matrix.This document contains Metrics, Graphics, a detailed Process Map and a practice summary Matrix.This document contains Metrics, Graphics, a detailed Process Map and a practice summary Matrix.This document contains Metrics, Graphics, a detailed Process Map and a practice summary Matrix.
Leading pharmaceutical companies have learned that team management is a complex process... (ID 4568)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline, more ...
Price: $823.95


Global Marketing Launch Strategy & Structure This document contains a practice summary Matrix.
In today’s crowded marketplace, pharmaceutical companies must develop a strategy that supports business objectives and forms an effective launch team for their product to achieve attention... (ID 4567)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline, more ...
Price: $812.95


Key Factors in Successful Global Pharmaceutical Launches This document contains Graphics.
Integrated global marketing launch systems generate rapid sales uptake and help produce blockbuster products that realize their maximum economic potential in the global marketplace... (ID 4564)
Companies Profiled: Sanofi-aventis, Merck, Eli Lilly, GlaxoSmithKline, more ...
Price: $274.95


Optimizing Commercial Resources for Pharmaceutical Launch Success This document contains Metrics and Graphics.This document contains Metrics and Graphics.
This document contains 17 pages that identify best practices in optimizing commercial resource support for pharmaceutical product launches... (ID 4294)
Companies Profiled: Abbott Laboratories, Eli Lilly and Company, Bristol-Myers Squibb, Bayer, more ...
Price: $2499.95


Launching Megabrands: Process Maps This document contains Graphics and a detailed Process Map.This document contains Graphics and a detailed Process Map.
The document consists of a 7 process maps highlighting the marketing best practices performed by leading pharmaceutical companies at various stages of the development process: Pre-Clinical, Phase I, Phase II, Phase III, Submission, and Launch... (ID 4107)
Companies Profiled: Pfizer, Sanofi-aventis, MErck, GlaxoSmithKline, more ...
Price: $839.95


Marketing Activities Matrix: Pharmaceutical Launch This document contains a practice summary Matrix.
... (ID 4106)
Companies Profiled: Leading Pharmaceutical Companies
Price: $86.95


Report Summary -- Thought Leader Relationships - Building the Business 
... (ID SM-129A)
Companies Profiled: A Leading Pharmaceutical Company, Sanofi-aventis, A Leading Pharmaceutical Firm, AstraZeneca, more ...
Price: $0.00


Thought Leader Relationships: Building the Business 
Build and manage thought leader relationships to drive successful launches characterized by rapid sales uptake, high market share, and extended product life cycles... (ID SM-129)
Companies Profiled: AstraZeneca, Sanofi-aventis, GlaxoSmithKline Merck, Pfizer, more ...
Price: $5438.00


Report Summary -- Best Practices in Global Pharmaceutical Launches 
For report summary, click "Buy Now"... (ID SM-120A)
Companies Profiled: AstraZeneca, Sanofi-aventis, Eli Lilly, GlaxoSmithKline, more ...
Price: $0.00


Show details for Quality, Compliance and RegulatoryQuality, Compliance and Regulatory
Show details for R and AS ConferencesR and AS Conferences
Show details for Sales and MarketingSales and Marketing
Show details for Sales LeadershipSales Leadership
Show details for Samples and Free ReportsSamples and Free Reports
Show details for (Not Categorized)(Not Categorized)

 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information